teaser
No evidence exists of a decreasing efficacy of drug-eluting stents (DESs) over time, and the safety profile of DESs does not appear to differ significantly from that of bare-metal stents, a study has found.
↓Article continues below this sponsored advert↓
Explore the latest advances in cardiovascular care delivered by renowned experts from recognised Centres of Excellence and other NHS trusts around the UK. Gain CPD, put your burning questions to the experts, and boost your confidence when it comes to care for your patients.
↑Advertisement↑
In this Italian study, the researchers analysed a real-world multicentre registry to investigate the effects of drug-eluting stents beyond one year of follow-up.
REAL, a large, prospective World Wide Web
